Home
Home

Lantus

News

Don't Ignore This Potential Blockbuster (taspoglutide; Roche)
The Motley Fool
»

News

Roche’s Diabetes Drug Meets Goals in Five Studies
Bloomberg
»

News

Ipsen, Roche’s Taspoglutide Matches Sanofi’s Lantus
Bloomberg
»

News

Sanofi Expands in Diabetes With Rights to Novel Drug
Bloomberg
»

News

Doctors Prescribe Caution With Sanofi Insulin’s Ties to Cancer
Bloomberg
»

News

Cancer Alert Probed as Sanofi, Novo Diabetes Drugs Put to Test
Bloomberg
»

News

Sanofi-aventis Welcomes The European Medicines Agency's Statement On Lantus® Safety
Medical News Today
»

News

Sanofi: Euro regulators deem Lantus safe
Marketwatch
»

News

Amylin Gets Positive Results
Yahoo/Zacks.com
»

News

Good News for Sanofi
Yahoo/Zacks.com
»